inner-banner-bg

International Journal of Diabetes & Metabolic Disorders(IJDMD)

ISSN: 2475-5451 | DOI: 10.33140/IJDMD

Impact Factor: 1.23

Gastric Sleeve analysis as a surgical treatment for obesity

Abstract

Castañeda Cruz JA, Montaño Pérez L, Corina, Rodelo Uraga MF and Molina Noyola LD

Introduction: Obesity is defined as the abnormal or excessive accumulation of fat that can be harmful to health. It is estimated that about 10 million people are severely obese in Mexico. Gastric Sleeve (GS) is the main procedure performed worldwide and has shown excellent results in treating obesity.

Materials and Methods: This is a retrospective study carried out by "Gastric Bypass Mexico" medical group from 2014 to 2016, where records of 1,030 patients who underwent a GS by 3 surgeons under the same technique were reviewed; Patients who were not approved by the multidisciplinary team were excluded.

Results: A total of 1,032 surgeries were performed, 814 (79.03%) to women; the averages are: age - 35.01 years old; BMI 40.16Kg / m2 (30-90.56 kg / m2); intrahospital stay 1.11 (1-5) days; surgical time 20.01 (15-35) minutes, anesthetic time 37.50 (30-102) minutes. The mortality rate was 0% and the complications percentage was 3.20% (33): 20 (1.94%) patients had bleeding, of which 7 (35%) required a globular package transfusion (1-3 units); 10 (0.97%) patients had an infection in a surgical wound, 2 (0.19%) had gastropleural fistula and 1 (0.97%) patient had a gastric leak.

Discussion: A GS is a safe and effective procedure for treating and controlling obesity. Compared to other techniques, a GS involves reduced anesthetic and surgical time, and offers short stays in the hospital. Conclusions: A GS offers excellent weight loss results, with a low morbidity and mortality rate.

PDF